Gastroenteropancreatic neuroendocrine tumors: Role of surgery

被引:4
|
作者
Sauvanet, Alain [1 ]
机构
[1] Univ Paris Diderot, Hop Beaujon, AP HP, Dept HPB Surg,PMAD, 100 Blvd Gen Leclerc, F-92110 Clichy, France
关键词
Gastroenteropancreatic neuroendocrine tumors; Pancreatectomy; Pancreatic insufficiency; Observation; LYMPH-NODE INVOLVEMENT; ENDOCRINE TUMORS; SURGICAL-MANAGEMENT; PANCREATIC INSUFFICIENCY; SHORT-TERM; RESECTION; SURVIVAL; CM; LYMPHADENECTOMY; METAANALYSIS;
D O I
10.1016/j.ando.2019.04.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural history of gastroenteropancreatic (GEP) Neuroendocrine tumors (NETs) is better and better known so indications of surgery are presently selective. Surgical resection, but also endoscopic resection and observation, can be proposed for gastric NETs according to presentation, size and grade. For small bowel NETs, resection is frequently needed but should obtain the best compromise between radicality and postoperative functional disorders. Appendiceal NETs are frequently diagnosed by appendectomy for appendicitis, but some patients at high risk for lymph node metastasis and recurrence should be reoperated for radical resection. Rectal NETs are often diagnosed incidentally; the smallest (< 1 cm) can be resected endoscopically but the most aggressive need a oncological proctectomy. Pancreatic NETs represent a wide spectrum, ranging from fully benign tumors to very aggressive ones. lnsulinomas are mostly benign, responsible for incapacitating symptoms despite medical treatment, and should ideally be treated by parenchyma sparing resection, mainly enucleation. Conversely, symptoms of gastrinomas are efficiently treated medically but their resection needs an oncological approach. Nonfunctioning PNETs are more and more frequently and incidentally discovered. According to their size, presentation and patient's characteristics, they need a resection (oncological or parenchyma-sparing) or a close observation. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [1] Surgery for Gastroenteropancreatic Neuroendocrine Tumors (GEPNETS)
    Boudreaux, J. Philip
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2011, 40 (01) : 163 - +
  • [2] The role of endoscopy in gastroenteropancreatic neuroendocrine tumors
    Magno, L.
    Sivero, L.
    Napolitano, V.
    Ruggiero, S.
    Fontanarosa, G.
    Massa, S.
    GIORNALE DI CHIRURGIA, 2010, 31 (6-7): : 341 - 343
  • [3] The prognostic role of radiomics in gastroenteropancreatic neuroendocrine tumors
    Magi, L.
    Polici, M.
    Rinzivillo, M.
    Caruso, D.
    Zerunian, M.
    Masci, B.
    Marasco, M.
    Laghi, A.
    Annibale, B.
    Panzuto, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 163 - 163
  • [4] Gastroenteropancreatic Neuroendocrine Tumors
    Cives, Mauro
    Strosberg, Jonathan R.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) : 471 - 487
  • [5] Gastroenteropancreatic neuroendocrine tumors
    Rayes, Nada
    Denecke, Timm
    ONKOLOGE, 2021, 27 (05): : 511 - 520
  • [6] Gastroenteropancreatic Neuroendocrine Tumors
    Breitling, Lutz Philipp
    Rinke, Anja
    Gress, Thomas Mathias
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (21) : 1509 - 1519
  • [7] Gastroenteropancreatic neuroendocrine tumors
    Rayes, Nada
    Denecke, Timm
    GASTROENTEROLOGE, 2021, 16 (06): : 469 - 479
  • [8] Gastroenteropancreatic Neuroendocrine Tumors
    Kotagal, Meera
    von Allmen, Daniel
    SEMINARS IN PEDIATRIC SURGERY, 2020, 29 (03)
  • [9] Gastroenteropancreatic neuroendocrine tumors
    Rayes, Nada
    Denecke, Timm
    RADIOLOGE, 2021, 61 (12): : 1129 - 1138
  • [10] Gastroenteropancreatic Neuroendocrine Tumors
    Fernandes, Conrad J.
    Leung, Galen
    Eads, Jennifer R.
    Katona, Bryson W.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (03) : 625 - 647